See your future through a different lens
Be NovalutionaryTM

If you find science, speed, and success exhilarating, you have come to the right place.

Novavax, Inc (Nasdaq:NVAX) is a biotechnology company that creates transformational vaccines that address some of the world’s most pressing infectious diseases.  We have more than a decade of experience contending with some of the world’s most devastating diseases, including COVID-19, seasonal influenza, RSV, Ebola, MERS, and SARS. Hard-won lessons and significant advances illustrate that our proven technology has tremendous potential to make a substantial contribution to public health worldwide.

Our scientists are committed to developing vaccine candidates for some of the world’s toughest viral threats by utilizing the power of our innovative recombinant nanoparticle vaccine platform.  Our vaccine technology combines the power and speed of genetic engineering with the immunogenicity enhancing properties of our Matrix-M™ adjuvant to efficiently produce highly immunogenic particles targeting some of the most pressing viral infectious diseases.

 

In conjunction with the European Market Access Lead, this role provides strategic market access leadership designed to build strong relationships and effective collaboration. In doing so, this role will help to shape key strategic decisions, including tendering and direct purchase strategies, Clinical Development and Integrated Evidence Generation Plans, to ensure that strategic plans fully meet the needs of market access. This role will take the lead in development of value propositions and deliver timely, optimal reimbursement in a highly challenging environment across diverse regions with complex and differing needs. Additionally, this role will be based in Germany

 Responsibilities include but are not limited to:

  • Be responsible for the strategic planning and implementation of the payer value generation and tender and/or direct purchase strategies, working in concert with marketing, government/policy and medical affairs experts dependent on solution to create holistic strategies.
  • Map external payer and funder environment and communicate to internal stakeholders and senior management relevant information regarding the current and future reimbursement landscape of key markets.
  • Responsible for evaluating threats and opportunities in key markets rising out of legislation, policies and regulation from WHO, MOH/government and/or private payers as well as competitive market access moves that can impact access of Novavax' products and pipeline and proactively develop strategies and plans to address the evolving reimbursement environment.
  • Maintain awareness of the reimbursement landscape and the political environment to ensure optimal development of recommendations and strategies
  • Deliver evidence planning to expand reimbursement to adjacent patient segments and new markets.
  • Guide core teams to ensure decisions to generate clinical and Real-World Evidence are taken early enough to support reimbursement and market adoption.
  • Be responsible for integrating pricing, payer research, health economic and epidemiology information to develop the optimal value strategy.
  • Champion real-world evidence generation and peer reviewed publication strategy to support and enhance clinical data.
  • Support Areas/Affiliates in addressing market access, price and reimbursement challenges.
  • Take budgetary responsibility for defining and managing the market access discretionary budgets, ensuring that spending is managed effectively throughout the year and to plan.

Minimum Requirements:

  • Requires Bachelor’s degree
  • A Masters’ Degree in a relevant discipling is preferred (e.g. Ph.D., Pharm D, MD, or M.Sc. in Epidemiology, Health Economics, Public Health or Health Policy).
  • A minimum of 8 years of professional experience in the pharmaceutical industry (global, regional or operating company level) with a focus in Epidemiology, Health Economics, Payer Access is required.
  • Recent experience working in the vaccine industry is mandatory.
  • An outstanding and significant network within the German Vaccines Market Access environment
  • Existing network to relevant institutions in Germany (for example, head organization of statutory health insurance, Leading health insurance coverage institutions and statutory health insurance institutions)
  • Understanding and/or experience of the reimbursement environment for Germany is required.
  • Deep understanding of Health Economics, meta-analyses, retrospective and prospective data generation activities, clinical trial methodologies, relative effectiveness and all other ingredients of an optimal value proposition and professional HTA or price & reimbursement submissions are required.
  • Demonstrated leadership ability to successfully work across functional and geographic boundaries, preferably across multiple countries/market types/access models, is required.
  • Deep appreciation of science and ability to translate scientific information into strategy is required.
  • An ability to manage multiple demands and priorities on time, influence without authority, gain alignment and drive decision making is required.
  • Excellent communication and leadership skills with a strong track record of producing results in a matrix-based environment are required.
  • Strong business acumen with ability to think strategically is required.

 

Travel: Approximately 40-50 % of the time

Every day our employees impact the future of health by preventing disease. To recognize their contributions, we offer them performance-based pay; a flexible, welcoming work environment; comprehensive and competitive benefits.

Novavax is headquartered in Gaithersburg, Maryland. Novavax is traded on the Nasdaq Stock Market under the symbol NVAX and is dedicated to developing novel vaccines to address infectious disease.

Novavax is an equal employment opportunity employer. Employment and advancement opportunities are available to all individuals regardless of their race, color, national origin, religion, ancestry, citizenship status, military or veteran status, sex, sexual orientation, gender identity or expression, age, marital status, family responsibilities, pregnancy, disability, genetic information, protective hairstyle, or any other protected characteristic.

#LI-SVH #LI-remote

Equal Opportunity Employer/Protected Veterans/Individuals with Disabilities

The contractor will not discharge or in any other manner discriminate against employees or applicants because they have inquired about, discussed, or disclosed their own pay or the pay of another employee or applicant. However, employees who have access to the compensation information of other employees or applicants as a part of their essential job functions cannot disclose the pay of other employees or applicants to individuals who do not otherwise have access to compensation information, unless the disclosure is (a) in response to a formal complaint or charge, (b) in furtherance of an investigation, proceeding, hearing, or action, including an investigation conducted by the employer, or (c) consistent with the contractor’s legal duty to furnish information. 41 CFR 60-1.35(c)

Job details
Business Development
Germany
Berlin, Germany, DEU
SENIO003580
Full-time
Not ready to Be Novalutionary?

Provide your interests and experience, and we'll keep you informed of relevant opportunities, news, and events with Novavax via email and text message updates.